[ Monteris Medical raises $26.6M in Series C ]
Monteris Medical has raised $26.6 million in Series C funding.
Founded in 1999, Monteris Medical designs, manufactures and markets MRI-guided laser ablation systems for the treatment of brain lesions. Monteris markets the NeuroBlate® System in the United States and Canada as a surgical tool that provides neurosurgeons an alternative to traditional craniotomies.
The company will use the funds raised to invest in further innovation, clinical research and commercial expansion.
|Founder / CEO||Marty Emerson|
|Investors||BDC Venture Capital|
|Previous Investors||Business Development Bank of Canada|
|Oxford Finance Corporation|
|The Vertical Group|
|BDC Venture Capital|
|SWMF Life Science Fund|